FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384277369> ?p ?o ?g. }

• W4384277369 endingPage "781" @default.
• W4384277369 startingPage "768" @default.
• W4384277369 abstract "Patients with capillary malformations (CMs) may undergo medical tattooing (MT) as an alternative to laser therapy. But little is known about treatment results and impact from the patients' perspective.In this cross-sectional digital survey study, we evaluated the patient-reported outcomes of MT for CMs.MT practices were identified via the Dutch Association of Skin Therapists and Google. These practices invited all their CM patients who had undergone MT between January 2011 and September 2021 to participate. Baseline and treatment characteristics, tattooing effectiveness, patient satisfaction with treatment outcomes, and complications were evaluated using a custom-made online survey. Quality of life was assessed with the Dermatology Life Quality Index (DLQI) questionnaire. Factors associated with treatment effectiveness and patient satisfaction were identified via bivariate analysis and ordinal logistic regression analysis.Most of the 89 respondents were female (69%). Almost all CMs were located on the face (90%) and mainly (dark) red (74%). Nearly all patients had undergone laser therapy (91%). Median number of tattooing sessions was 5 (IQR: 4.0-8.0). Thirty-seven percent of the patients perceived >75% color reduction. Younger patients were more likely to obtain lower treatment effectiveness (OR 0.44, 95% CI: 0.20-0.97). Most patients (83%) were satisfied with treatment results. Patients with lighter (OR 0.30, 95% CI: 0.13-0.72), non-facial (OR 0.15, 95% CI: 0.03-0.89), and hypertrophic CMs (OR 0.30, 95% CI: 0.11-0.82) were less likely to be satisfied with treatment outcomes. Patients with lighter skin types were more satisfied (OR 2.89, 95% CI: 1.23-6.80). Complications included transient pain (23%), bleeding (3.4%), hypertrophic scarring (1.1%), hypopigmentation (1.1%), and a halo around the tattoo (1.1%).MT seems a valid alternative treatment in addition to laser therapy for CMs, with mild complications. Most patients are (very) satisfied with treatment results, while color reduction is incomplete. Hence, it seems appropriate to decide together with patients whether or not to use MT as primary treatment or secondary to laser therapy." @default.
• W4384277369 created "2023-07-15" @default.
• W4384277369 creator A5004798669 @default.
• W4384277369 creator A5017029863 @default.
• W4384277369 creator A5026692174 @default.
• W4384277369 creator A5026697149 @default.
• W4384277369 creator A5037914232 @default.
• W4384277369 creator A5045462582 @default.
• W4384277369 creator A5074481954 @default.
• W4384277369 creator A5084784237 @default.
• W4384277369 creator A5087475694 @default.
• W4384277369 creator A5092122440 @default.
• W4384277369 creator A5092468501 @default.
• W4384277369 date "2023-01-01" @default.
• W4384277369 modified "2023-10-14" @default.
• W4384277369 title "Patient-Reported Outcomes of Medical Tattooing for Capillary Malformations" @default.
• W4384277369 cites W1495133610 @default.
• W4384277369 cites W1966856182 @default.
• W4384277369 cites W1967878375 @default.
• W4384277369 cites W1973106737 @default.
• W4384277369 cites W1985741335 @default.
• W4384277369 cites W1988515370 @default.
• W4384277369 cites W1988747600 @default.
• W4384277369 cites W1995554908 @default.
• W4384277369 cites W2003495710 @default.
• W4384277369 cites W2008494218 @default.
• W4384277369 cites W2011493444 @default.
• W4384277369 cites W2028398671 @default.
• W4384277369 cites W2034727226 @default.
• W4384277369 cites W2038672330 @default.
• W4384277369 cites W2047345777 @default.
• W4384277369 cites W2064087142 @default.
• W4384277369 cites W2073334071 @default.
• W4384277369 cites W2089683968 @default.
• W4384277369 cites W2096991001 @default.
• W4384277369 cites W2162399955 @default.
• W4384277369 cites W2170852605 @default.
• W4384277369 cites W2262061239 @default.
• W4384277369 cites W2299648251 @default.
• W4384277369 cites W2560554043 @default.
• W4384277369 cites W2777848068 @default.
• W4384277369 cites W2940590702 @default.
• W4384277369 cites W3040569237 @default.
• W4384277369 cites W3110278551 @default.
• W4384277369 cites W3154790864 @default.
• W4384277369 cites W3157025521 @default.
• W4384277369 cites W3159087541 @default.
• W4384277369 cites W3175231292 @default.
• W4384277369 cites W3204881762 @default.
• W4384277369 doi "https://doi.org/10.1159/000530609" @default.
• W4384277369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37442102" @default.
• W4384277369 hasPublicationYear "2023" @default.
• W4384277369 type Work @default.
• W4384277369 citedByCount "0" @default.
• W4384277369 crossrefType "journal-article" @default.
• W4384277369 hasAuthorship W4384277369A5004798669 @default.
• W4384277369 hasAuthorship W4384277369A5017029863 @default.
• W4384277369 hasAuthorship W4384277369A5026692174 @default.
• W4384277369 hasAuthorship W4384277369A5026697149 @default.
• W4384277369 hasAuthorship W4384277369A5037914232 @default.
• W4384277369 hasAuthorship W4384277369A5045462582 @default.
• W4384277369 hasAuthorship W4384277369A5074481954 @default.
• W4384277369 hasAuthorship W4384277369A5084784237 @default.
• W4384277369 hasAuthorship W4384277369A5087475694 @default.
• W4384277369 hasAuthorship W4384277369A5092122440 @default.
• W4384277369 hasAuthorship W4384277369A5092468501 @default.
• W4384277369 hasBestOaLocation W43842773691 @default.
• W4384277369 hasConcept C120665830 @default.
• W4384277369 hasConcept C121332964 @default.
• W4384277369 hasConcept C126322002 @default.
• W4384277369 hasConcept C141071460 @default.
• W4384277369 hasConcept C142052008 @default.
• W4384277369 hasConcept C142724271 @default.
• W4384277369 hasConcept C151956035 @default.
• W4384277369 hasConcept C159110408 @default.
• W4384277369 hasConcept C1862650 @default.
• W4384277369 hasConcept C205545832 @default.
• W4384277369 hasConcept C2775944032 @default.
• W4384277369 hasConcept C2779951463 @default.
• W4384277369 hasConcept C2993195213 @default.
• W4384277369 hasConcept C520434653 @default.
• W4384277369 hasConcept C71924100 @default.
• W4384277369 hasConceptScore W4384277369C120665830 @default.
• W4384277369 hasConceptScore W4384277369C121332964 @default.
• W4384277369 hasConceptScore W4384277369C126322002 @default.
• W4384277369 hasConceptScore W4384277369C141071460 @default.
• W4384277369 hasConceptScore W4384277369C142052008 @default.
• W4384277369 hasConceptScore W4384277369C142724271 @default.
• W4384277369 hasConceptScore W4384277369C151956035 @default.
• W4384277369 hasConceptScore W4384277369C159110408 @default.
• W4384277369 hasConceptScore W4384277369C1862650 @default.
• W4384277369 hasConceptScore W4384277369C205545832 @default.
• W4384277369 hasConceptScore W4384277369C2775944032 @default.
• W4384277369 hasConceptScore W4384277369C2779951463 @default.
• W4384277369 hasConceptScore W4384277369C2993195213 @default.
• W4384277369 hasConceptScore W4384277369C520434653 @default.
• W4384277369 hasConceptScore W4384277369C71924100 @default.
• W4384277369 hasIssue "5" @default.

• next